Gainers
Windtree Therapeutics, Inc (NASDAQ: WINT) rose 50.7% to $0.4827 in pre-market trading after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European Journal of Heart Failure.
Gainers
ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 58% to $2.75 in pre-market trading after jumping 26% on Thursday. ToughBuilt Industries reported closing of $6 million public offering.